current

Hunt Valley, MD
Investment Date: 2016

Contract development and manufacturing organization providing dosage form development, commercial manufacturing services, and developing a profit-share pipeline.


Private
Munich, Germany
Investment Date: 2015

Developer of proprietary formulation technology that addresses low bioavailability and solubility


Private
Clearwater, FL
Investment Date: 2015

Contract developer and manufacturer of complex oral drugs


Private
Copenhagen, Denmark
Investment Date: 2015

Manufacturer of complex API's


Private
Riviera Beach, FL
Investment Date: 2014

Integrated specialty pharmaceutical company leveraging proprietary formulation technology


Private
Princeton, NJ
Investment Date: 2014

Developer and marketer of complex generic pharmaceuticals.


Private
Malvern, PA
Investment Date: 2014

Medtech company focused on surgical mesh products for soft tissue repair


Private
Cambridge, MA
Investment Date: 2014

Diagnostics and personalized medicine platform focused on Oncology


Private
Concord, Ontario, Canada
Investment Date: 2013

Developer of nasal and inhaled drug-device combination generic therapeutics


Private
Sunnyvale, CA
Investment Date: 2013

Developer of injectable ophthalmic drug-device combination therapeutics


Private
Ahmedabad, India
Investment Date: 2012

Provider of specialty generic injectable drugs


Public (BSE: 533288)
San Francisco, CA
Investment Date: 2011

Developer of instruments and microfluidic chips for cell based drug assays


Private
Buena, NJ
Investment Date: 2009

Developer, manufacturer and marketer of topical and injectable pharmaceuticals


Public (NSDQ: TLGT)
San Diego, CA
Investment Date: 2009

Protein expression company focused on development of biosimilar drugs


Public (NSDQ: PFNX)
Amsterdam, Netherlands
Investment Date: 2006

Specialty pharmaceutical company focused on European markets


Private
Hayward, CA
Investment Date: 2005

Developer of automated bedside monitoring devices for critical care


Private
Mezzovico, Switzerland
Investment Date: 2004

Developer and manufacturer of orally dispersible tablet formulations


Private

Realized

Somerset, NJ
Investment Date: 2014

Developer and manufacturer of complex API's


Acquired by Medicure
Atlanta, GA
Investment Date: 2010

Specialty pharmaceutical company focused on cardiovascular and pediatric disorders


Acquired by KKR
Leiden, Netherlands
Investment Date: 2009

Specialty pharmaceutical company focused on controlled release formulations


Acquired by Dr. Reddy’s Laboratories
Cambridge, MA
Investment Date: 2007

Provider of dental implants


Acquired by AstraZeneca
Geneva, Switzerland
Investment Date: 2007

Developer, manufacturer and marketer of injectable biopolymers (fillers)


Acquired by Merz
Minneapolis, MN
Investment Date: 2007

Developer of novel electrosurgical tools for ENT and other surgical applications


Acquired by Medtronic
Berlin, Germany
Investment Date: 2005

Developer and manufacturer of peptide-based drugs for neglected diseases


IPO, Acquired by Shire Pharmaceuticals
Sunrise, FL
Investment Date: 2005

Developer and manufacturer of controlled release generic drugs


Acquired by Actavis
Chennai, India
Investment Date: 2005

Developer and manufacturer of APIs


Acquired by Private Equity Fund
San Francisco, CA
Investment Date: 2005

Marketer of in-licensed oncology products for Asian markets


Acquired by Management
Lenexa, KS
Investment Date: 2004

Provider of technology to enhance solubility and absorption of drugs


Acquired by Ligand
Tigard, OR
Investment Date: 2004

Developer of needle-free injection systems


Acquired by Inovio
Cranbury, NJ
Investment Date: 2003

Specialty pharmaceutical company focused on urology & endocrinology


IPO, Acquired by Indevus (Endo)
Anaheim, CA
Investment Date: 2003

Specialty pharmaceutical company focused on CNS indications


Public market exit
Carlsbad, CA
Investment Date: 2003

Contract manufacturer of viral vaccines and therapeutics


Acquired by Sigma-Aldrich
Amsterdam, Netherlands
Investment Date: 2003

Provider of R&D tools & services to pharmaceutical & chemical companies


Acquired by AESCAP
Grafton, WI
Investment Date: 2003

Developer and manufacturer of API's


Acquired by AMRI
Köln, Germany
Investment Date: 2002

Developer of proteins and enzymes for industrial & biopharmaceutical applications


Acquired by Bayer HealthCare
Pittsburgh, PA
Investment Date: 2001

Provider of hardware & software for radiation therapy


Acquired by North American Scientific
Investment Date: 2000
Pharma Marketing

A specialty pharmaceutical company with products marked in the U.S. and Europe. Acquired by Elan Corporation


Acquired by Elan Corporation
Cranbury, NJ
Investment Date: 2001

Developer, manufacturer and marketer of generic pharmaceuticals


Public market exit
Durham, NC
Investment Date: 2001

Developer of vaccines for treatment of cancer and infectious diseases


Public market exit
Bedminster, NJ
Investment Date: 2000

Commercial specialty pharmaceuticals company


Public market exit
Philadelphia, PA
Investment Date: 1999

Provider of cardiac monitoring software


Public market exit